HERA

Dec 29 2024HEALTH

COPD: Which Triple-Inhaler Therapy Works Better?

Chronic obstructive pulmonary disease (COPD) can be rough. It causes flare-ups that lower quality of life and can even be deadly. When dual therapy isn't enough, doctors often recommend a single-inhaler triple therapy (SITT). Two common ones are fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/V

reading time less than a minute
Dec 28 2024CELEBRITIES

Shaquille O'Neal's New Path to Better Health: A Neck Therapy and Water Intake Journey

Shaquille O’Neal, the legendary 4x NBA champion, has been on a journey to improve his health. Recently, he's been dealing with some neck pain that's been around for a while. To tackle this issue, he tried out a new therapy called Hydrofascial Release. This treatment aims to loosen up tight areas in

reading time less than a minute
Dec 27 2024HEALTH

Exploring How Chemo Changes Immune Cells in Lung Cancer

Chemotherapy is a common treatment for lung adenocarcinoma, but it has its limitations. So, scientists are looking into how it affects our body's defense system. They studied cells from nine patients who either had surgery or chemotherapy before surgery. They found that chemotherapy changes how immu

reading time less than a minute
Dec 27 2024HEALTH

Are Some Breast Cancer Patients Spared Surgery After Chemo?

You might wonder why some breast cancer patients still undergo surgery after chemotherapy. The answer involves a specific group of patients with a particular cancer stage. These patients, whose cancer is classified as ypN1 after neoadjuvant chemotherapy (NAC), are in a bit of a gray area. Doctors ar

reading time less than a minute
Dec 27 2024HEALTH

Updating Skills for Pediatric Physical Therapists: A New Competency Framework

Pediatric physical therapists play a crucial role in helping kids with physical challenges. Recently, experts decided to revise the core competencies these professionals need. Why the change? Well, healthcare is always evolving, and so are the needs of children. The goal is to ensure therapists stay

reading time less than a minute
Dec 27 2024HEALTH

Monitoring Infliximab for Ulcerative Colitis: Is It Worth the Cost?

Managing ulcerative colitis (UC) often involves using a drug called infliximab (IFX). But should doctors track the drug's levels in the body (a process known as therapeutic drug monitoring, or TDM) to improve outcomes? The answer isn't clear-cut; TDM might provide better results, but is it cost-effe

reading time less than a minute
Dec 26 2024HEALTH

Therapy and Brain Stimulation: A Powerful Pair for Mental Health

Did you know that your brain can change and adapt over time? This is called neural plasticity. Both your experiences and treatments like therapy can influence it. Noninvasive brain stimulation (NIBS) uses things like magnetic fields to affect specific brain areas. This can improve mood or reduce anx

reading time less than a minute
Dec 26 2024HEALTH

Unraveling the Power of Phasing in Skin Diseases

Imagine trying to solve a puzzle where you need to match the right pieces together. In the world of genetics, this is called phasing—figuring out which genes on chromosome pairs go together. This process is crucial for diagnosing and treating certain skin diseases, like recessive dystrophic epidermo

reading time less than a minute
Dec 26 2024HEALTH

New Hope for Young Adults with Glioma: The Introduction of VoraSidenib

Isocitrate dehydrogenase (IDH)-mutant gliomas frequently strike young adults, causing severe brain tumors that disrupt their lives. These tumors are notorious for hindering cognitive abilities and, sadly, often lead to death. Current treatments, though life-prolonging, have serious side effects, dam

reading time less than a minute
Dec 26 2024HEALTH

Unraveling the Real-World Success of Enfortumab Vedotin for Advanced Bladder Cancer

Let's dive into the effectiveness of Enfortumab Vedotin (EV) in tackling advanced urothelial carcinoma (a severe form of bladder cancer) in the real world. EV is a unique drug that combines two powerful actions: it targets the nectin-4 protein found in cancer cells and disrupts their structure by in

reading time less than a minute